The Modern Financial Terminal

Subscribe for $2

Trusted by leading companies and financial institutions

USANA Health Sciences Stock USNA

Currency:

Price

18.73 USD

Today +/-

-1.93 USD

Today %

-9.83 %

Ticker
USNA

ISIN
US90328M1071

USANA Health Sciences stock price

Weekly

Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the USANA Health Sciences stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the USANA Health Sciences stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the USANA Health Sciences stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze USANA Health Sciences's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

USANA Health Sciences Stock Price History

Date	USANA Health Sciences Price
2/18/2026	18.73 USD
2/16/2026	20.66 USD
2/12/2026	20.90 USD
2/11/2026	20.96 USD
2/10/2026	21.14 USD
2/9/2026	21.43 USD
2/8/2026	21.20 USD
2/5/2026	21.34 USD
2/4/2026	20.81 USD
2/3/2026	20.90 USD
2/2/2026	20.44 USD
2/1/2026	21.66 USD
1/29/2026	21.70 USD
1/28/2026	21.68 USD
1/27/2026	21.37 USD
1/26/2026	22.14 USD
1/25/2026	22.22 USD
1/22/2026	22.53 USD
1/21/2026	22.51 USD
1/20/2026	22.24 USD
1/19/2026	21.97 USD

USANA Health Sciences Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Revenue

EBIT

Net Income

Details

USANA Health Sciences Income Statement, Balance Sheet, Cash Flow Statement

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M USD)

NET INCOME (M USD)

NET INCOME GROWTH (%)

SHARES (M)

DOCUMENTS

1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e
0.01	0.02	0.06	0.09	0.13	0.13	0.12	0.11	0.13	0.2	0.26	0.32	0.37	0.42	0.43	0.44	0.52	0.58	0.65	0.72	0.79	0.92	1.01	1.05	1.19	1.06	1.13	1.19	1	0.92	0.85	0.94	0.98	1.04
–	242.86	137.50	54.39	43.18	6.35	-8.21	-7.32	16.67	50.38	29.50	21.62	15.87	15.89	1.42	1.63	18.58	12.38	11.53	10.80	10.03	16.20	9.59	4.08	13.56	-10.85	6.98	4.59	-15.85	-7.72	-7.27	10.42	3.39	6.15
71.43	75.00	77.19	76.14	76.19	77.61	69.92	71.05	75.19	77.50	77.61	78.10	78.08	79.20	79.25	79.59	81.62	82.62	82.10	82.17	82.15	82.57	82.01	82.81	83.10	82.36	81.57	81.62	80.56	80.78	81.15	73.49	71.08	66.96
5	18	44	67	96	104	86	81	100	155	201	246	285	335	340	347	422	480	532	590	649	758	825	867	988	873	925	968	804	744	693	0	0	0
0	2	5	6	9	5	2	2	8	20	30	38	40	45	29	33	45	24	66	79	76	94	100	62	126	100	124	116	69	63	42	32	36	52
–	–	150.00	20.00	50.00	-44.44	-60.00	–	300.00	150.00	50.00	26.67	5.26	12.50	-35.56	13.79	36.36	-46.67	175.00	19.70	-3.80	23.68	6.38	-38.00	103.23	-20.63	24.00	-6.45	-40.52	-8.70	-33.33	-23.81	12.50	44.44
42.5	46.4	53.3	53.3	55.7	49.9	39.6	38.8	41.3	42.6	40.8	39.4	37.4	34.4	32.3	30.9	31.9	31.1	29.8	28.4	27.4	26.4	25	24.7	24.6	22.8	21.3	20.3	19.3	19.35	19.16	0	0	0
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Keystats

ⓘ

Revenue and Growth

The USANA Health Sciences Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the USANA Health Sciences is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

ASSETS

CASH BALANCE (M USD)

RECEIVABLES (k USD)

OTHER RECEIVABLES (M USD)OTHER REC. (M USD)

INVENTORIES (M USD)

OTHER CURRENT ASSETS (M USD)OTHER CURRENT LIAB. (M USD)

CURRENT ASSETS (M USD)

TANGIBLE ASSETS (M USD)

LONG-TERM INVESTMENTS (M USD)LONG-T. INVEST. (M USD)

LONG-TERM RECEIVABLES (M USD)LONG-T. REC. (M USD)

INTANGIBLE ASSETS (M USD)INTANGIBLE ASSETS (M USD)

GOODWILL (M USD)

OTHER NON-CURRENT ASSETS (M USD)OTHER NON-CURRENT ASSETS (M USD)

NON-CURRENT ASSETS (M USD)

TOTAL ASSETS (M USD)

LIABILITIES

COMMON STOCK (M USD)

ADDITIONAL PAID-IN CAPITAL (M USD)

RETAINED EARNINGS (M USD)

OTHER EQUITY (M USD)OTHER EQUITY (M USD)

UNREALIZED GAINS/LOSSES (M USD)UNREAL. GAINS/LOSSES (M USD)

EQUITY (M USD)

LIABILITIES (M USD)

PROVISIONS (M USD)

OTHER SHORT-TERM LIABILITIES (M USD)OTHER SHORT-TERM LIAB. (M USD)

SHORT-TERM DEBTS (M USD)SHORT-TERM DEBTS (M USD)

SHORT-TERM PORTION OF LONG-TERM DEBTS (M USD)LONG-TERM DEBT PORTION (M USD)

SHORT-TERM RECEIVABLES (M USD)SHORT-TERM REC. (M USD)

LONG-TERM LIABILITIES (M USD)LONG-T. LIAB. (M USD)

DEFERRED TAXES (M USD)

OTHER LIABILITIES (M USD)OTHER LIAB. (M USD)

LONG-TERM LIABILITIES (M USD)LONG-T. LIABILITIES (M USD)

DEBT (M USD)

TOTAL CAPITAL (M USD)

1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2022	2023	2024

3	1.1	2.6	2.6	1.4	2.9	2.5	6.7	19	15.1	10.6	27	12.9	13.3	13.7	27.3	50.4	70.8	146	111.1	143.2	175.8	247.1	277.9	234.8	311.9	239.8	239.83	288.4	330.42	181.77
0	100	100	300	500	400	300	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0.4	0	0	0.3	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
2.1	6.4	6.5	10.5	9.9	10.9	9.5	9.1	14.1	17.7	22.2	22.5	19.4	23.9	25.8	34.1	37	36.5	47.2	45.2	66.1	64.8	62.9	81.9	68.9	90.2	98.3	98.32	67.1	61.45	69.74
0.3	1	2	3.1	2.9	1.4	1.9	3	3.8	4.3	5.5	6.1	5.6	6.4	6.5	8.7	9.1	11.2	16.7	18.1	19.9	14.8	13.6	16.5	15.2	13.7	17.6	17.53	18.5	17.49	18.57
5.4	9	11.2	16.5	15	17	14.2	18.8	36.9	37.1	38.3	55.6	37.9	43.6	46	70.1	96.5	118.5	209.9	174.4	229.2	255.4	323.6	376.3	318.9	415.8	355.7	355.68	374	409.36	270.07
4.6	11.6	15	22.8	21.5	17.6	19.5	18.4	20.2	23.2	23.3	30.3	52.1	56.8	57.2	166.4	60.8	61.8	59.2	71.2	88	101.3	102.8	92	126.5	128.4	125.6	125.57	117.8	117.49	115.74
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	125.3	42.6	42.1	42.3	41	38.3	34.3	35.2	31.8	29.8	30.8	30.4	30.44	32.4	29.92	151.82
0	0	0	0	0	0	0	0	4.3	5.7	5.7	5.7	5.7	5.7	5.7	17.3	17.7	17.9	18.2	17.9	17.4	16.7	17.4	16.8	16.6	17.4	17.7	17.67	17.4	17.1	144.17
0.2	0.4	0.1	0.1	0.2	1	1.7	1.8	2.4	2	2.9	3.4	5.4	7.4	8.6	-174	17.3	13.1	19.7	29.6	35.3	40.5	23.7	21.5	14.7	39	38.9	38.94	44.6	30.51	57.27
4.8	12	15.1	22.9	21.7	18.6	21.2	20.2	26.9	30.9	31.9	39.4	63.2	69.9	71.5	135	138.4	134.9	139.4	159.7	179	192.8	179.1	162.1	187.6	215.6	212.6	212.62	212.2	215.01	469.01
10.2	21	26.3	39.4	36.7	35.6	35.4	39	63.8	68	70.2	95	101.1	113.5	117.5	205.1	234.9	253.4	349.3	334.1	408.2	448.2	502.7	538.4	506.5	631.4	568.3	568.31	586.2	624.38	739.08

6	6.8	7.2	9.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.02	0	0.02	0.02
0	0	0	-0.5	2.9	2.4	2.4	3.7	14.2	11.9	9.2	15.6	5.6	8.1	16.4	51.2	49.3	43.8	54.7	61.6	69.7	71.5	76.5	72	59.4	62.5	50	50.01	55.6	65.66	75.82
0.6	5.6	12.2	21.7	10.1	10.6	12.8	14.5	28.9	34.5	35.7	44.3	26.3	24.1	56.4	90.2	118.8	134.8	200	166.4	214.9	265.4	288.1	329.5	306.1	382.8	344.6	344.64	391.6	445.22	478.94
0	0	-0.1	-0.2	0	-0.1	-0.6	-0.1	1.2	1.5	0.8	0.4	1	-0.4	1.5	5.4	5.8	6.9	5.8	2.1	-3.8	-11.6	-1.4	-10.4	-13.9	-3.6	0.5	0.46	-12.8	-13.7	-22.67
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
6.6	12.4	19.3	30.1	13	12.9	14.6	18.1	44.3	47.9	45.7	60.3	32.9	31.8	74.3	146.8	173.9	185.5	260.5	230.1	280.8	325.3	363.2	391.1	351.6	441.7	395.1	395.12	434.4	497.2	532.11
1.2	4.7	3.2	4.2	4.1	3.4	2.6	2.7	5.2	5.1	5	10.2	8.1	6.9	5.8	6.4	8	7	9.5	7.8	10	9	11.8	9.9	12.5	18.2	13.5	13.51	11	10.07	11.98
0.5	1.3	1.4	1.8	1.5	1.3	1.2	3.5	5.9	6.7	8.6	11.1	14.3	15.1	12.2	19.1	16.5	21	25.9	28	34.6	34.9	34.3	40.4	40.8	53.3	50.8	50.78	35.5	32.71	43.47
1.9	1.1	2.1	2.7	6	2.8	3.9	5.1	8.9	11	13	18.5	23.5	32.5	22.5	33.5	35.2	42.8	60.5	72.9	86.8	94.5	95.1	98.3	82.8	96.6	96.5	96.51	97.3	75.28	61.17
0	1.5	0	0	2.8	7.2	4.1	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	2	0	2	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.79	23
3.6	8.6	6.7	8.7	16.4	14.7	13.8	17.6	20	22.8	26.6	39.8	45.9	54.5	40.5	59	59.7	70.8	95.9	108.7	131.4	138.4	141.2	148.6	136.1	168.1	160.8	160.79	143.8	118.85	139.63
0	0	0	0	7.5	8	6	2.6	0	0	0	0	28	35	7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0.1	0.4	0.6	0	0	1	0.8	0.8	1.1	1.4	0	0	0	0	9.8	9.9	10	10.9	10.6	9.8	5.5	13.7	13.4	10.3	12	7.5	7.5	4.1	4.55	4.07
0	0	0	0	0	0	0	0	0	0	0	0	2.3	1.2	1.6	1	0.9	0.9	1.2	1.1	1.2	1.4	1.1	1.3	18.8	19.2	14.3	14.33	14.2	12.16	18.16
0	0.1	0.4	0.6	7.5	8	7	3.4	0.8	1.1	1.4	0	30.3	36.2	8.6	10.8	10.8	10.9	12.1	11.7	11	6.9	14.8	14.7	29.1	31.2	21.8	21.83	18.3	16.71	22.24
3.6	8.7	7.1	9.3	23.9	22.7	20.8	21	20.8	23.9	28	39.8	76.2	90.7	49.1	69.8	70.5	81.7	108	120.4	142.4	145.3	156	163.3	165.2	199.3	182.6	182.62	162.1	135.56	161.86
10.2	21.1	26.4	39.4	36.9	35.6	35.4	39.1	65.1	71.8	73.7	100.1	109.1	122.5	123.4	216.6	244.4	267.2	368.5	350.5	423.2	470.6	519.2	554.4	516.8	641	577.7	577.74	596.5	632.76	693.97

Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of USANA Health Sciences provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand USANA Health Sciences's financial health and stability.

Assets

USANA Health Sciences's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that USANA Health Sciences must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of USANA Health Sciences after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into USANA Health Sciences's financial standing, aiding in investment evaluations and risk assessments.

NET INCOME (M USD)

DEPRECIATION AND AMORTIZATION M USDDEPRECIATION (M USD)

DEFERRED TAXES (M USD)

CHANGES IN WORKING CAPITAL (M USD)CHANGES IN WORKING CAPITAL (M USD)

NON-CASH ITEM (M USD)

PAID INTEREST (k USD)

PAID TAXES (M USD)

Net Cash Flow from Operating Activities (M USD)NET CASH FLOW FROM OPERATING ACTIVITIES (M USD)

CAPITAL EXPENDITURES (M USD)

CASH FLOW FROM INVESTING ACTIVITIES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (M USD)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)

INTEREST INCOME AND EXPENSES (M USD)

NET DEBT CHANGE (M USD)NET DEBT CHANGE (M USD)

Net change in equity (M USD)NET CHANGE IN EQUITY (M USD)

CASH FLOW FROM FINANCING ACTIVITIES (M USD)CASH FLOW FROM FINANCING ACTIVITIES (M USD)

OTHER ITEMS OF FINANCING CASH FLOWS (M USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M USD)

TOTAL DIVIDENDS PAID (M USD)

NET CHANGE IN CASH FLOW (M USD)

FREE CASH FLOW (M USD)

SHARE-BASED COMPENSATION (M USD)

1994	1995	1996	1997	1998	1999			2000	2001	2002	2003	2004			2005	2006	2007	2008	2009		2010			2011	2012	2013	2014	2015			2016	2017	2018	2019	2020	2021	2022	2022	2023
0	2	5	6	9	5	9	5	2	2	8	20	30	20	30	39	40	45	29	33	29	45	33	45	50	66	79	76	94	76	94	100	62	126	100	124	116	116	69	63
0	0	0	2	3	4	3	4	4	4	4	3	4	3	4	5	5	5	6	7	6	7	7	7	8	8	9	8	10	8	9	13	16	16	14	13	13	13	13	12
0	0	0	0	0	0	0	0	0	1	-1	0	0	0	0	0	-1	-1	-2	-2	-2	3	-2	3	-1	4	0	-1	-2	-1	-2	-3	19	0	-3	-2	-3	-2	-7	-2
0	1	-1	-1	-3	0	-3	0	-3	1	2	9	0	9	0	1	13	3	5	-15	5	1	-15	1	1	6	9	25	10	25	10	10	7	-7	-8	0	-28	-28	6	-27
0	0	0	0	1	4	1	4	0	0	1	1	1	1	1	1	3	6	13	18	6	18	9	8	21	17	7	4	10	-4	0	33	33	31	39	38	37	23	34	39
0	0	0	0	0	0	0	0	1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	4	3	5	4	5	4	4	1	3	2	9	2	9	15	19	25	20	22	20	21	22	21	24	27	27	27	35	26	35	52	46	70	54	53	59	59	45	42
0	3	4	7	10	15	10	15	4	10	15	35	38	35	38	48	61	58	46	32	46	66	32	66	70	92	98	105	111	105	111	137	123	152	126	160	121	121	103	70
0	-4	-7	-5	-11	-4	-11	-4	-5	-6	-3	-4	-7	-4	-7	-4	-11	-26	-16	-4	-16	-4	-4	-4	-10	-8	-8	-20	-23	-20	-23	-32	-13	-11	-16	-15	-12	-12	-16	-14
0	-3	-7	-4	-11	-4	-11	-4	-2	-6	-2	-9	-9	-9	-9	-5	-11	-26	-15	-3	-15	-46	-3	-46	-10	-8	-21	-16	-25	-16	-25	-31	-12	-69	47	-34	-14	-14	-12	-11
0	0	0	1	0	0	0	0	2	0	0	-5	-2	-5	-2	-1	0	0	0	0	0	-42	0	-42	0	0	-13	4	-1	4	-1	0	0	-57	64	-18	-1	-1	4	2
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	1	-1	0	10	0	10	2	-3	-3	-9	0	-9	0	0	0	28	7	-28	7	-7	-28	-7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	2	0	0	1	-23	1	-23	-2	0	-6	-4	-33	-4	-33	-46	-37	-76	-39	-1	-39	-5	-1	-5	-33	-68	-17	-127	-61	-127	-61	-64	-50	-105	-150	-57	-177	-177	-25	-11
0	2	1	-1	1	-11	1	-11	0	-3	-9	-13	-33	-13	-33	-46	-33	-46	-29	-29	-29	-9	-29	-9	-33	-64	-10	-113	-49	-113	-49	-64	-50	-105	-152	-59	-181	-181	-30	-14
0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	4	1	2	0	2	2	0	2	0	3	7	14	12	14	12	0	0	0	-2	-2	-3	-3	-4	-3
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	2	-1	1	0	-1	0	-1	1	0	4	12	-3	12	-3	-4	16	-14	0	0	0	10	0	10	26	20	66	-26	32	-26	32	32	71	-33	20	78	-72	-72	47	41
0.3	-0.3	-3.6	1.8	-0.7	10.1	0	0	-1.2	3.4	12.9	30.9	31.2	0	0	43.7	50.3	31.9	29.9	28.4	0	61.9	0	0	59.5	84.4	90.8	84.8	87.8	0	0	104.3	110.6	140.7	110.1	145.3	108.4	0	87	56.15
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

USANA Health Sciences stock margins

The USANA Health Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of USANA Health Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for USANA Health Sciences.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Gross margin

EBIT margin

Profit margin

Details

USANA Health Sciences Stock Sales Revenue, EBIT, Earnings per Share

The USANA Health Sciences earnings per share therefore indicates how much revenue USANA Health Sciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Sales per Share

EBIT per share

Earnings per Share

Details

USANA Health Sciences business model

USANA Health Sciences Inc is an American company that was founded in 1992 by Dr. Myron Wentz. Originally headquartered in Salt Lake City, Utah, the company now operates in over 20 countries worldwide. The main mission of USANA is to help people live healthier lives through high-quality supplements and a healthy lifestyle. USANA is a direct sales company, which means that its products are sold by independent distributors. These distributors earn a commission on their sales and can also have additional income opportunities by building a network of distributors. USANA's business model is based on the idea that people can improve their well-being and enhance their lives by using high-quality supplements and adopting a healthy lifestyle. USANA offers a wide range of products in various categories, including supplements for adults and children, weight management products, personalized vitamins and minerals, skincare products, as well as energy and fitness products. The quality of USANA's products is ensured through strict quality assurance measures and independent certification by NSF International, a third-party company that verifies the safety and efficacy of supplements. USANA also has several divisions, including USANA Health Sciences, Inc., USANA Pacific, Ltd., and BabyCare Ltd. USANA Health Sciences, Inc. is the company's main focus, specializing in the development and distribution of health-related products. USANA Pacific Ltd. is a wholly independent company that focuses on developing and distributing products for customers in Australia, New Zealand, and Asia. BabyCare Ltd. is a company specialized in manufacturing skincare products for babies. USANA has also established a charitable organization, the USANA Foundation, to carry out philanthropic work in various communities around the world. The USANA Foundation addresses basic needs such as health, education, and nutrition and supports organizations dedicated to helping children in need. In summary, USANA Health Sciences Inc is a company that is dedicated to improving people's health and well-being. Its direct sales model and use of high-quality ingredients and supplements certified by an independent third party have helped to build consumer trust in USANA's products. USANA has also expanded its reach through the establishment of various divisions and the creation of a charitable organization, allowing it to have a positive impact on many people worldwide. USANA Health Sciences is one of the most popular companies on Eulerpool.com.

USANA Health Sciences SWOT Analysis

Helpful

Harmful

Internal

Strengths

1. Strong Brand Reputation: USANA Health Sciences Inc has built a strong reputation in the health and wellness industry, known for its high-quality products and commitment to scientific research.

2. Extensive Product Line: The company offers a wide range of nutritional supplements, personal care products, and healthy food choices, catering to diverse customer needs.

3. Established Presence: With operations in multiple countries, USANA has a global presence, allowing it to tap into different markets and reach a larger customer base.

Weaknesses

1. Dependency on Distributor Network: USANA relies heavily on its network of independent distributors for sales and marketing, making it vulnerable to fluctuations in distributor performance and retention.

2. Intense Competition: The health and wellness market is highly competitive, with numerous established players and new entrants vying for market share. USANA needs to continuously innovate to stay ahead of the competition.

3. Product Pricing: USANA's products are priced at a premium compared to some competitors, limiting their accessibility to price-sensitive customers.

External

Opportunities

1. Growing Health Consciousness: The increasing consumer focus on health and wellness presents an opportunity for USANA to expand its customer base and market its products to individuals seeking healthier lifestyles.

2. Emerging Markets: USANA can explore and expand into emerging markets where there is a rising demand for health and wellness products, such as Asia and Latin America.

3. E-commerce Expansion: With the growing popularity of online shopping, USANA can invest in enhancing its e-commerce capabilities, allowing customers to conveniently purchase their products online.

Threats

1. Regulatory Challenges: The health and wellness industry is subject to stringent regulations and standards. USANA faces the risk of increased regulatory scrutiny, which could impact its operations and product offerings.

2. Economic Uncertainty: Global economic fluctuations and recessions can affect consumer spending on health products, potentially impacting USANA's revenue and profitability.

3. Negative Public Perception: Any adverse incidents or controversies related to the health and wellness industry can tarnish USANA's brand image and erode consumer trust.

USANA Health Sciences Revenue by Region

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Details

USANA Health Sciences Eulerpool Fair Value

Loading chart...

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

USANA Health Sciences historical P/E ratio, EBIT multiple, and P/S ratio

USANA Health Sciences shares outstanding

The number of shares was USANA Health Sciences in 2025 — This indicates how many shares 19.162 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Number of stocks

Details

USANA Health Sciences stock splits

In USANA Health Sciences's history, there have been no stock splits.

Unfortunately, there are currently no price targets and forecasts available for USANA Health Sciences.

USANA Health Sciences Earnings Calls

USANA Health Sciences Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
2/17/2026	0.42 USD	230.48 M USD	2025 Q4
4/23/2024	0.75 USD	230.72 M USD	2024 Q1
2/5/2024	0.53 USD	217.26 M USD	2023 Q4
7/24/2023	1.02 USD	255.02 M USD	2023 Q2
4/24/2023	0.9 USD	249.26 M USD	2023 Q1
2/6/2023	0.36 USD	206.84 M USD	2022 Q4
10/25/2022	0.91 USD	247.86 M USD	2022 Q3
7/26/2022	1.16 USD	272.48 M USD	2022 Q2
4/26/2022	1.16 USD	271.33 M USD	2022 Q1
2/8/2022	1.31 USD	276.01 M USD	2021 Q4
10/26/2021	1.33 USD	272.09 M USD	2021 Q3
7/27/2021	1.75 USD	337.6 M USD	2021 Q2
4/27/2021	1.51 USD	306 M USD	2021 Q1
2/9/2021	1.46 USD	295.92 M USD	2020 Q4
10/20/2020	1.29 USD	282.99 M USD	2020 Q3
7/21/2020	1.1 USD	260.17 M USD	2020 Q2
4/21/2020	0.85 USD	244.29 M USD	2020 Q1
2/4/2020	1 USD	256.54 M USD	2019 Q4
10/22/2019	0.88 USD	265.15 M USD	2019 Q3
7/23/2019	0.95 USD	258.4 M USD	2019 Q2
4/30/2019	1.01 USD	276.17 M USD	2019 Q1
2/5/2019	1.35 USD	312.31 M USD	2018 Q4
10/23/2018	1.14 USD	296.11 M USD	2018 Q3
7/24/2018	1.13 USD	285.38 M USD	2018 Q2
4/24/2018	1.08 USD	279 M USD	2018 Q1
2/6/2018	1.02 USD	261.67 M USD	2017 Q4
10/24/2017	0.92 USD	263.37 M USD	2017 Q3
7/25/2017	1.17 USD	288.71 M USD	2017 Q2
5/2/2017	0.94 USD	257.32 M USD	2017 Q1
2/7/2017	0.96 USD	257.32 M USD	2016 Q4
10/25/2016	1.09 USD	267.32 M USD	2016 Q3
7/26/2016	1.05 USD	260.51 M USD	2016 Q2
5/3/2016	0.92 USD	247.71 M USD	2016 Q1
2/9/2016	1.01 USD	242.49 M USD	2015 Q4
11/3/2015	0.9 USD	227.89 M USD	2015 Q3
8/4/2015	0.82 USD	216.13 M USD	2015 Q2
5/5/2015	0.66 USD	201.38 M USD	2015 Q1
2/10/2015	0.98 USD	222.03 M USD	2014 Q4
10/28/2014	0.7 USD	193.36 M USD	2014 Q3
7/29/2014	0.77 USD	201.27 M USD	2014 Q2
4/29/2014	0.66 USD	188.64 M USD	2014 Q1
2/4/2014	0.62 USD	178.28 M USD	2013 Q4
10/22/2013	0.58 USD	174.99 M USD	2013 Q3
7/23/2013	0.68 USD	179.05 M USD	2013 Q2
4/23/2013	0.59 USD	174.34 M USD	2013 Q1
2/5/2013	0.62 USD	168.29 M USD	2012 Q4
10/23/2012	0.54 USD	164.06 M USD	2012 Q3
7/24/2012	0.47 USD	157.35 M USD	2012 Q2
4/24/2012	0.35 USD	147.5 M USD	2012 Q1
2/7/2012	0.44 USD	146.57 M USD	2011 Q4
10/25/2011	0.39 USD	144.43 M USD	2011 Q3
7/26/2011	0.41 USD	149.54 M USD	2011 Q2
4/26/2011	0.34 USD	132.73 M USD	2011 Q1
2/8/2011	0.43 USD	138.97 M USD	2010 Q4
10/26/2010	0.33 USD	125.35 M USD	2010 Q3
7/27/2010	0.32 USD	124.85 M USD	2010 Q2
4/27/2010	0.26 USD	108.25 M USD	2010 Q1
2/9/2010	0.3 USD	117.4 M USD	2009 Q4
10/27/2009	0.26 USD	111.71 M USD	2009 Q3
7/28/2009	0.23 USD	101.49 M USD	2009 Q2
4/28/2009	0.2 USD	106.07 M USD	2009 Q1
2/23/2009	0.29 USD	113.7 M USD	2008 Q4
10/14/2008	0.31 USD	113.37 M USD	2008 Q3
7/22/2008	0.31 USD	109.84 M USD	2008 Q2
4/21/2008	0.23 USD	101.58 M USD	2008 Q1
2/5/2008	0.34 USD	111.01 M USD	2007 Q4
10/16/2007	0.34 USD	108.04 M USD	2007 Q3
7/16/2007	0.32 USD	105.77 M USD	2007 Q2
4/17/2007	0.31 USD	105.41 M USD	2007 Q1
2/6/2007	0.3 USD	101.37 M USD	2006 Q4
10/17/2006	0.29 USD	96.76 M USD	2006 Q3
7/18/2006	0.27 USD	94.64 M USD	2006 Q2
4/18/2006	0.27 USD	89.25 M USD	2006 Q1
2/7/2006	0.26 USD	88.51 M USD	2005 Q4
10/18/2005	0.25 USD	84.45 M USD	2005 Q3
7/19/2005	0.24 USD	80.29 M USD	2005 Q2
4/19/2005	0.22 USD	78.76 M USD	2005 Q1
2/8/2005	0.21 USD	72.32 M USD	2004 Q4
10/19/2004	0.19 USD	70.09 M USD	2004 Q3
7/20/2004	0.17 USD	65.28 M USD	2004 Q2
4/20/2004	0.15 USD	60.99 M USD	2004 Q1
2/3/2004	0.15 USD	57.85 M USD	2003 Q4
10/14/2003	0.14 USD	53.69 M USD	2003 Q3
7/15/2003	0 USD	0 USD	2003 Q2
4/15/2003	0 USD	0 USD	2003 Q1
1/28/2003	0 USD	0 USD	2002 Q4
10/15/2002	0 USD	0 USD	2002 Q3
7/15/2002	0 USD	0 USD	2002 Q2
6/5/2002	0 USD	0 USD	2002 Q1

...

Eulerpool ESG Scorecard© for the USANA Health Sciences stock

Eulerpool World ESG Rating (EESG©)

54/ 100

🌱 Environment

👫 Social

🏛️ Governance

Environment

Scope 1 - Direct Emissions	1,429.7
Scope 2 - Indirect emissions from purchased energy	935.9
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions	2,365.6
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees	58
Percentage of women in management
Percentage of Asian employees	55
Share of Asian management	55
Percentage of Hispanic/Latino employees	14
Hispano/Latino Management share	6
Percentage of Black employees	1
Black Management Share
Percentage of white employees	27
White Management Share	37
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

USANA Health Sciences shareholders

%	Name	Stocks	Change	Date
42.34871 %	Gull Global, Ltd.	7,741,345	-142,398	3/10/2025
8.43346 %	BlackRock Institutional Trust Company, N.A.	1,541,637	-78,007	6/30/2025
6.63341 %	Pzena Investment Management, LLC	1,212,588	14,328	9/30/2025
6.31745 %	Renaissance Technologies LLC	1,154,830	69,566	6/30/2025
5.41455 %	The Vanguard Group, Inc.	989,779	-362,125	6/30/2025
5.00574 %	Dimensional Fund Advisors, L.P.	915,049	17,318	9/30/2025
2.33230 %	State Street Investment Management (US)	426,344	-25,022	6/30/2025
1.91797 %	Jacobs Levy Equity Management, Inc.	350,605	162,094	6/30/2025
1.69870 %	Geode Capital Management, L.L.C.	310,523	-9,731	6/30/2025
1.39513 %	American Century Investment Management, Inc.	255,029	-213	6/30/2025
1.24802 %	Charles Schwab Investment Management, Inc.	228,138	54,141	6/30/2025
0.93329 %	Parametric Portfolio Associates LLC	170,606	46,161	6/30/2025
0.91011 %	Citadel Advisors LLC	166,368	28,073	6/30/2025
0.85546 %	Morgan Stanley & Co. LLC	156,378	-16,836	6/30/2025
0.82106 %	Columbia Threadneedle Investments (US)	150,090	58,921	6/30/2025
0.69055 %	Goldman Sachs Asset Management, L.P.	126,232	101,436	6/30/2025
0.67007 %	Millennium Management LLC	122,488	-7,122	6/30/2025
0.61421 %	Northern Trust Investments, Inc.	112,278	-9,221	6/30/2025
0.60137 %	Aperio Group, LLC	109,931	39,849	6/30/2025
0.55901 %	Assenagon Asset Management S.A.	102,187	-2,223	9/30/2025
0.55129 %	Nuveen LLC	100,775	67,901	6/30/2025
0.53357 %	Connor, Clark & Lunn Investment Management Ltd.	97,537	65,268	6/30/2025
0.52858 %	Invesco Capital Management LLC	96,624	1,317	6/30/2025
0.41365 %	D. E. Shaw & Co., L.P.	75,616	-71,032	6/30/2025
0.39861 %	BofA Global Research (US)	72,865	18,244	6/30/2025
0.36570 %	Algert Global LLC	66,850	66,850	6/30/2025
0.35967 %	BlackRock Financial Management, Inc.	65,747	-9,433	6/30/2025
0.29940 %	Mellon Investments Corporation	54,731	-3,295	6/30/2025
0.29312 %	Principal Global Investors (Equity)	53,582	-1,494	6/30/2025
0.28921 %	Bridgeway Capital Management, LLC	52,867	2,384	6/30/2025
0.27822 %	Nordea Funds Oy	50,859	-777	9/30/2025
0.27341 %	Royce Investment Partners	49,979	5,144	6/30/2025
0.27284 %	Two Sigma Investments, LP	49,875	49,875	6/30/2025
0.25823 %	Exchange Traded Concepts, LLC	47,204	39,297	9/30/2025
0.25071 %	Walleye Capital LLC	45,829	33,001	6/30/2025
0.24463 %	UBS Financial Services, Inc.	44,718	-8,017	6/30/2025
0.22458 %	BlackRock Investment Management, LLC	41,053	6,747	6/30/2025
0.22228 %	Goldman Sachs & Company, Inc.	40,632	-11,129	6/30/2025
0.20911 %	Barclays Bank PLC	38,226	9,096	6/30/2025
0.20746 %	6 Meridian LLC	37,924	37,924	9/30/2025
0.20159 %	PSP Investments	36,851	1,788	6/30/2025
0.19897 %	Dimensional Fund Advisors, Ltd.	36,371	0	9/30/2025
0.19760 %	DWS Investments UK Limited	36,121	964	6/30/2025
0.19653 %	Teacher Retirement System of Texas	35,925	10,442	9/30/2025
0.18619 %	Rhumbline Advisers Ltd. Partnership	34,036	-2,269	6/30/2025
0.17018 %	Verition Fund Management LLC	31,108	31,108	6/30/2025
0.16121 %	Guest (Kevin G)	29,469	1	3/10/2025
0.16082 %	Legal & General Investment Management Ltd.	29,397	-355	6/30/2025
0.15729 %	BlackRock Advisors (UK) Limited	28,752	147	9/30/2025
0.15245 %	ETF Architect	27,867	2,384	6/30/2025
0.15066 %	Acadian Asset Management LLC	27,541	15,806	6/30/2025
0.13798 %	Aquatic Capital Management LLC	25,223	15,569	6/30/2025
0.13660 %	BlackRock Asset Management Ireland Limited	24,970	-4,610	6/30/2025
0.13185 %	Brown (Jim H)	24,102	1,218	7/24/2025
0.12879 %	Numeric Investors LLC	23,542	-45,286	6/30/2025
0.12867 %	Ohio Public Employees Retirement System	23,520	7,943	6/30/2025
0.12692 %	Lazard Asset Management, L.L.C.	23,201	13,128	6/30/2025
0.12037 %	Vanguard Investments Australia Ltd.	22,004	0	6/30/2025
0.11858 %	BNY Mellon Asset Management	21,676	892	6/30/2025
0.11816 %	Schweizerische Nationalbank	21,600	-700	6/30/2025
0.11800 %	PGIM Quantitative Solutions LLC	21,571	-669	6/30/2025
0.11462 %	Susquehanna International Group, LLP	20,952	-4,449	6/30/2025
0.11427 %	PIMCO (US)	20,889	20,889	6/30/2025
0.10969 %	Creative Planning, Inc.	20,051	613	6/30/2025
0.10947 %	Quadrant Family Wealth Advisors	20,011	13,159	6/30/2025
0.10886 %	KLP Kapitalforvaltning AS	19,900	0	9/30/2025
0.10358 %	Martingale Asset Management, L.P.	18,934	1,392	6/30/2025
0.09985 %	UBS Asset Management (Switzerland)	18,253	10,376	6/30/2025
0.09850 %	Mariner Wealth Advisors	18,006	-416	6/30/2025
0.09847 %	State Teachers Retirement System of Ohio	18,000	14,600	9/30/2025
0.09847 %	Unison Advisors LLC	18,000	0	6/30/2025
0.09248 %	Tidal Investments LLC	16,906	5,318	6/30/2025
0.08996 %	Inspire Investing	16,444	16,444	9/30/2025
0.08976 %	Denali Advisors, LLC	16,409	0	6/30/2025
0.08838 %	Horizon Investments, LLC	16,155	3,299	6/30/2025
0.08280 %	State of Wisconsin Investment Board	15,136	15,136	6/30/2025
0.08197 %	Invesco Advisers, Inc.	14,985	-1,088	6/30/2025
0.07979 %	AQR Capital Management, LLC	14,586	-7,259	6/30/2025
0.07928 %	Research Affiliates, LLC	14,493	14,493	6/30/2025
0.07867 %	Citi Investment Research (US)	14,380	-3,670	6/30/2025
0.07834 %	Vident Asset Management	14,321	14,321	6/30/2025
0.07580 %	Polymer Capital Management (US), LLC	13,857	13,857	6/30/2025
0.07559 %	Arrowstreet Capital, Limited Partnership	13,818	13,818	6/30/2025
0.06931 %	AllianceBernstein L.P.	12,670	1,600	6/30/2025
0.06893 %	New York State Teachers' Retirement System	12,600	114	9/30/2025
0.06513 %	Franklin Advisers, Inc.	11,905	1,659	6/30/2025
0.06477 %	Versor Investments LP	11,840	-1,160	6/30/2025
0.06411 %	Magnetar Capital Partners LP	11,720	-303	6/30/2025
0.06253 %	Numerai Gp LLC	11,430	-10,558	6/30/2025
0.06224 %	Jump Financial, LLC	11,377	11,377	6/30/2025
0.05848 %	California State Teachers Retirement System	10,690	0	6/30/2025
0.05722 %	T. Rowe Price International Ltd	10,460	1,521	6/30/2025
0.05578 %	HSBC Global Asset Management (UK) Limited	10,196	-4,554	6/30/2025
0.05530 %	Jane Street Capital, L.L.C.	10,109	-29,302	6/30/2025
0.05449 %	BlackRock Investment Management (UK) Ltd.	9,961	0	6/30/2025
0.05357 %	SEI Investments Management Corporation	9,793	0	9/30/2025
0.05281 %	Centiva Capital, LP	9,653	-1,832	6/30/2025
0.05071 %	SG Americas Securities, L.L.C.	9,269	9,269	9/30/2025
0.05066 %	Mulham (David Mulham)	9,260	-3,515	7/30/2025
0.05056 %	BNP Paribas Securities Corp. North America	9,243	8,379	6/30/2025

...

USANA Health Sciences Executives and Management Board

Mr. Jim Brown

(56)

USANA Health Sciences President, Chief Executive Officer

Compensation 3.36 M USD

Mr. Kevin Guest

(62)

USANA Health Sciences Executive Chairman of the Board (since 2004)

Compensation 1.82 M USD

Mr. G. Hekking

(55)

USANA Health Sciences Chief Financial Officer

Compensation 1.44 M USD

Mr. Walter Noot

(59)

USANA Health Sciences Chief Operating Officer

Compensation 1.44 M USD

Mr. Brent Neidig

(41)

USANA Health Sciences Chief Commercial Officer

Compensation 1.3 M USD

USANA Health Sciences Supply Chain

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Verint Systems	SupplierCustomer	0,28	0,82	-0,07	-0,02	-0,45	0,53

Most common questions regarding USANA Health Sciences

USANA Health Sciences Inc operates through a direct selling business model. The company manufactures and distributes science-based nutritional and personal care products. USANA's business model involves independent associates who sell its products directly to customers, earning commissions and bonuses based on their sales and the sales of their team. This model allows USANA to bypass traditional retail channels and establish a strong relationship with its customers. With a focus on health and wellness, USANA Health Sciences Inc aims to provide high-quality products that promote a healthy lifestyle and support optimal well-being.

Sector

Non-cyclical consumption

Industry

Personal Products

Number of shares

18,280,000

Employees

1,909

Revenue growth Ø5 years

-5.51 %

EBIT growth Ø5 years

-17.78 %

Net Income growth Ø5 years

-19.55 %

Website usana.com

Country

🇺🇸

Currency

USD

Initial public offering

Oct 28, 1993

ISIN

US90328M1071

Cusip

90328M107

Sedol

2267698

Market capitalization

382.07 M USD

USANA Health Sciences Directors Dealings

Quality Investing

Details

3 / 10

PEG

0.49

P/E ratio

8.54

Forward P/E ratio 2025

11.06

Forward P/E ratio 2026

9.87

Forward P/E ratio 2027

6.85

P/S ratio

0.42

Forward P/S ratio

0.38

ROE (Return on Equity)

7.9 %

ROA (Return on Assets)

5.62 %

ROCE (Return on Capital Employed)

10.9 %

ROIC (Return on Invested Capital)

USANA Health Sciences Peer Group

Coty Inc

Estee Lauder Companies Inc

Medifast Inc

Inter Parfums Inc

Edgewell Personal Care Co

NU Skin Enterprises Inc

USANA Health Sciences Eulerpool News

USANA Health Sciences Earnings Calls

No Earnings Calls available for USANA Health Sciences

USANA Health Sciences News

All USANA Health Sciences News

USANA Health Sciences Ticker

Stock Exchange	USANA Health Sciences Ticker
FRANKFURT	USJ.F
MUNICH	USJ.MU
NEW YORK	USNA
SIX	USJ.SW

USANA Health Sciences FIGI

USANA Health Sciences Ticker	USANA Health Sciences FIGI
USNA:US	BBG000BX28M0
USNA:UA	BBG000BX29L9
USNA:UC	BBG000BX2B52
USNA:UN	BBG000BX2BQ9
USNA:UP	BBG000BX2CG8
USNA:UB	BBG000BX2DL0
USNA:UT	BBG000BX2DR4
USNA:UM	BBG000BX2FG1
USNA:UX	BBG000BX2FW3
USNA:UD	BBG000BX2JY3
USNA:UF	BBG000BX2L87
USNA:VY	BBG000BX2LL2
USNA:VJ	BBG000BX2LZ7
USNA:VK	BBG000BX2MJ3
USJ:GR	BBG000L0XWL5
USJ:GF	BBG000L0YYF7
USJ:GS	BBG000L103J6
USJ:GM	BBG000L103W1
USNA:VF	BBG00DJD6F11
USJ:GZ	BBG00FGX0YF5
USNAEUR:X2	BBG00JPC6V09
USNAEUR:XB	BBG00JPC6V18
USNAEUR:XH	BBG00JPC6V36
USNAEUR:XF	BBG00JPC6V54
USNAEUR:XE	BBG00JPC6V72
USNAEUR:XJ	BBG00JPC6V81
USNAEUR:XL	BBG00JPC6V90
USNAEUR:XG	BBG00JPC6VB7
USNAEUR:XO	BBG00JPC6VC6
USNAEUR:XS	BBG00JPC6VH1
USNAEUR:XA	BBG00JPC6VJ9
USNAEUR:E1	BBG00JPC6VK7
USNAEUR:XT	BBG00JPC6VL6
USNAEUR:XW	BBG00JPC6VM5
USNAEUR:XU	BBG00JPC6VN4
USNAEUR:XV	BBG00JPC6VP2
USNAEUR:XM	BBG00JPC6VQ1
USNAEUR:XQ	BBG00JPC6VS9
USNAEUR:XX	BBG00JPC6VT8
USNAEUR:XZ	BBG00JPC6VV5
USNAEUR:EU	BBG00JPC6VX3
USNAUSD:XS	BBG00KL6R295
USNAUSD:XH	BBG00KL6R2D0
USNAUSD:XF	BBG00KL6R2G7
USNAUSD:XE	BBG00KL6R2J4
USNAUSD:XJ	BBG00KL6R2K2
USNAUSD:XL	BBG00KL6R2L1
USNAUSD:XG	BBG00KL6R2M0
USNAUSD:XO	BBG00KL6R2N9
USNAUSD:XA	BBG00KL6R2S4
USNAUSD:E1	BBG00KL6R2T3
USNAUSD:XT	BBG00KL6R2V0
USNAUSD:XW	BBG00KL6R2W9
USNAUSD:XU	BBG00KL6R2X8
USNAUSD:XV	BBG00KL6R2Y7
USNAUSD:XM	BBG00KL6R2Z6
USNAUSD:XQ	BBG00KL6R311
USNAUSD:XX	BBG00KL6R320
USNAUSD:XZ	BBG00KL6R339
USNAUSD:EU	BBG00KL6R357
USNAGBP:XS	BBG00L2TPFD2
USNAGBP:XH	BBG00L2TPFH8
USNAGBP:XF	BBG00L2TPFL3
USNAGBP:XE	BBG00L2TPFN1
USNAGBP:XJ	BBG00L2TPFP9
USNAGBP:XL	BBG00L2TPFQ8
USNAGBP:XG	BBG00L2TPFR7
USNAGBP:XO	BBG00L2TPFS6
USNAGBP:XA	BBG00L2TPFY9
USNAGBP:E1	BBG00L2TPFZ8
USNAGBP:XT	BBG00L2TPG04
USNAGBP:XW	BBG00L2TPG13
USNAGBP:XU	BBG00L2TPG22
USNAGBP:XV	BBG00L2TPG31
USNAGBP:XM	BBG00L2TPG40
USNAGBP:XQ	BBG00L2TPG77
USNAGBP:XX	BBG00L2TPG86
USNAGBP:XZ	BBG00L2TPG95
USNAGBP:EU	BBG00L2TPGG7
USJ:SW	BBG00LVGHYV6
USJ:BW	BBG00LVGHZ16
USNA:VG	BBG00X1LJY04
USNA:VP	BBG00X1PZ6Z0
USNAUSD:EP	BBG00XDH9KN6
USNAUSD:EZ	BBG00XDH9KQ3
USJ:LA	BBG018H7SRR8
USJ:LU	BBG018J1FVC0

All fundamentals about USANA Health Sciences

Our stock analysis for USANA Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of USANA Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

The Modern Financial Terminal

Trusted by leading companies and financial institutions

USANA Health Sciences Stock USNA

Price

Price

TickerUSNA

ISINUS90328M1071

USANA Health Sciences stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

USANA Health Sciences Revenue, EBIT, Net Income

USANA Health Sciences Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

USANA Health Sciences stock margins

USANA Health Sciences Stock Sales Revenue, EBIT, Earnings per Share

USANA Health Sciences business model

USANA Health Sciences SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

USANA Health Sciences Revenue by Region

The World’s Best Investors Are On Eulerpool

USANA Health Sciences Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

USANA Health Sciences historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

USANA Health Sciences shares outstanding

USANA Health Sciences stock splits

The World’s Best Investors Are On Eulerpool

USANA Health Sciences Earnings Calls

USANA Health Sciences Earnings Estimates

Eulerpool ESG Scorecard© for the USANA Health Sciences stock

Eulerpool World ESG Rating (EESG©)

54/ 100

🌱 Environment

👫 Social

🏛️ Governance

Environment

Social

Governance (Corporate Governance)

USANA Health Sciences shareholders

USANA Health Sciences Executives and Management Board

Mr. Jim Brown

Mr. Kevin Guest

Mr. G. Hekking

Mr. Walter Noot

Mr. Brent Neidig

USANA Health Sciences Supply Chain

Most common questions regarding USANA Health Sciences

What is the business model of USANA Health Sciences?

In which industries is USANA Health Sciences primarily active?

Who are the main competitors of USANA Health Sciences in the market?

What is the history and background of the company USANA Health Sciences?

What significant milestones has the company USANA Health Sciences achieved?

In which countries and regions is USANA Health Sciences primarily present?

What values and corporate philosophy does USANA Health Sciences represent?

Ticker
USNA

ISIN
US90328M1071